Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Liuying Township, Taiwan Clinical Trials

A listing of Liuying Township, Taiwan clinical trials actively recruiting patients volunteers.

Found (3334) clinical trials

Do you have Rheumatoid Arthritis? WCCT Global is seeking volunteers who have been diagnosed with Rheumatoid Arthritis for at least 6 months to participate in a medical research study with an investigational medication. Participants may receive: Up to $2,350 for time and travel Study related care at no cost Investigational …

Phase

Diablo Clinical Research is conducting a clinical research study to evaluate an investigational medication in postmenopausal women to see its effect on cholesterol. You may qualify for the study if you are: A woman Post menopausal In good general health Not using hormone therapy Qualified participants may receive at no …

Phase

What is the purpose of this study? The goals of this study are: To find the highest safe dose of Sorafenib that can be given to children with solid tumors without causing severe side effects To find out if the highest safe dose of Sorafenib in children with solid tumors …

Phase

Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma

There are a number of brain tumor studies including those in NCI consortium that are not including temozolomide for increased toxicity with novel agents or other drugs when added to temozolomide and radiation. However,if the combination of ibrutinib and radiation in unmethylated MGMT glioblastoma patient population is safe at every …

Phase

Mechanism of Non-invasive Magnetic Stimulation

Objectives: The goal of the protocol is to investigate acute modulations of brain activity by transcranial magnetic stimulation (TMS). Using simultaneous TMS and functional magnetic resonance imaging (fMRI), we will evaluate TMS induced changes in brain activity, including regional brain activation and inter-regional functional connectivity. Repetitive TMS will be applied …

Phase

A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy

The study is primarily designed to assess the safety and tolerability of escalating oral doses of Debio 1143 and preliminary anti-tumour activity when combined with the standard dose of avelumab in participants with advanced solid malignancies.

Phase

Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

PRIMARY OBJECTIVES: I. To determine the safety of niclosamide (PDMX1001/niclosamide) and enzalutamide in patients with castration-resistant prostate cancer (CRPC). II. To determine the recommended phase II dose (RP2D) of PDMX1001/niclosamide and enzalutamide for the treatment of patients with CRPC. SECONDARY OBJECTIVES: I. To determine the pharmacokinetics of PDMX1001/niclosamide. II. To …

Phase

A Study of LY3361237 in Participants With Systemic Lupus Erythematosus

The main purpose of this study is to learn more about the safety of LY3361237 and any side effects that might be associated with it when given to participants with systemic lupus erythematosis (SLE). LY3361237 will be administered by injections just under the skin. The study will last up to …

Phase

This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours)

The primary objective of this trial is to determine the maximum tolerated dose (MTD) of BI 905677 given as an intravenous infusion and to determine the recommended dose and dosing schedule for further trials in the development of BI 905677. The MTD will be defined based on the frequency of …

Phase

Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study

Spina bifida can be a devastating neurological congenital anomaly. It results from incomplete closure of the neural tube between 22 and 28 embryological days. Its incidence is approximately 1-2 per 1,000 births. It is considered the most common congenital anomaly of the central nervous system compatible with life. The most …

Phase